Prognostic Value of Fluorine-19 MRI Oximetry Monitoring in cancer

Fanny Chapelin, Roberto Gedaly, Zachary Sweeney, Liza J. Gossett

Research output: Contribution to journalReview articlepeer-review

5 Scopus citations

Abstract

Hypoxia is a key prognostic indicator in most solid tumors, as it is correlated to tumor angiogenesis, metastasis, recurrence, and response to therapy. Accurate measurement and mapping of tumor oxygenation profile and changes upon intervention could facilitate disease progression assessment and assist in treatment planning. Currently, no gold standard exists for non-invasive spatiotemporal measurement of hypoxia. Magnetic resonance imaging (MRI) represents an attractive option as it is a clinically available and non-ionizing imaging modality. Specifically, perfluorocarbon (PFC) beacons can be externally introduced into the tumor tissue and the linear dependence of their spin-lattice relaxation rate (R1) on the local partial pressure of oxygen (pO2) exploited for real-time tissue oxygenation monitoring in vivo. In this review, we will focus on early studies and recent developments of fluorine-19 MRI and spectroscopy (MRS) for evaluation of tumor oximetry and response to therapy.

Original languageEnglish
Pages (from-to)208-219
Number of pages12
JournalMolecular Imaging and Biology
Volume24
Issue number2
DOIs
StatePublished - Apr 2022

Bibliographical note

Publisher Copyright:
© 2021, World Molecular Imaging Society.

Keywords

  • Cancer
  • Fluorine-19 (F)
  • Hypoxia
  • MRI
  • Oximetry
  • Perfluorocarbon (PFC)

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Fingerprint

Dive into the research topics of 'Prognostic Value of Fluorine-19 MRI Oximetry Monitoring in cancer'. Together they form a unique fingerprint.

Cite this